FDA
-
-
-
-
-
-
-
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
-
-
-
-
-
-
-
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
-
-
-
-
-
-
-
CVRx Reports First Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
-
-
-
-
-
-
-
CVRx announces new CPT® Category I codes for Barostim
-
-
-
-
-
-
-
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
-
-
-
-
-
-
-
CVRx Announces Key Senior Leadership Team Hires
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

